Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker EDSA
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Nov 9, 2026 | EDSA Edesa Biotech, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Nov 9, 2026 | EDSA Edesa Biotech, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Nov 9, 2026 | EDSA Edesa Biotech, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 23, 2026 | EDSA Edesa Biotech, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Oct 15, 2026 | EDSA Edesa Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 20, 2026 | EDSA Edesa Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 20, 2026 | EDSA Edesa Biotech, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Aug 13, 2026 | EDSA Edesa Biotech, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Jun 11, 2026 | EDSA Edesa Biotech, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jun 11, 2026 | EDSA Edesa Biotech, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jun 11, 2026 | EDSA Edesa Biotech, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 5, 2026 | EDSA Edesa Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| May 29, 2026 | EDSA Edesa Biotech, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 29, 2026 | EDSA Edesa Biotech, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 15, 2026 | EDSA Edesa Biotech, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 14, 2026 | EDSA Edesa Biotech, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 24, 2026 | EDSA Edesa Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 13, 2026 | EDSA Edesa Biotech, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Dec 12, 2025 | EDSA Edesa Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Dec 12, 2025 | EDSA Edesa Biotech, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 28, 2025 | EDSA Edesa Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Sep 30, 2025 | EDSA Edesa Biotech, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Sep 30, 2025 | EDSA Edesa Biotech, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Sep 9, 2025 | EDSA Edesa Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Aug 8, 2025 | EDSA Edesa Biotech, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| May 28, 2025 | EDSA Edesa Biotech, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| May 28, 2025 | EDSA Edesa Biotech, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| May 14, 2025 | EDSA Edesa Biotech, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Apr 4, 2025 | EDSA Edesa Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Apr 4, 2025 | EDSA Edesa Biotech, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 14, 2025 | EDSA Edesa Biotech, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Feb 13, 2025 | EDSA Edesa Biotech, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Feb 13, 2025 | EDSA Edesa Biotech, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Feb 13, 2025 | EDSA Edesa Biotech, Inc. | 5.02 Departure or Election of Directors or Officers; Compensatory Arrangements | 8-K | 8-K ↗ |
| Feb 13, 2025 | EDSA Edesa Biotech, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Feb 13, 2025 | EDSA Edesa Biotech, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Feb 13, 2025 | EDSA Edesa Biotech, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Dec 13, 2024 | EDSA Edesa Biotech, Inc. | 2.02 Results of Operations and Financial Condition | 8-K | 8-K ↗ |
| Oct 31, 2024 | EDSA Edesa Biotech, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Oct 31, 2024 | EDSA Edesa Biotech, Inc. | 3.03 Material Modification to Rights of Security Holders | 8-K | 8-K ↗ |
| Oct 31, 2024 | EDSA Edesa Biotech, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Oct 31, 2024 | EDSA Edesa Biotech, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Oct 31, 2024 | EDSA Edesa Biotech, Inc. | 1.02 Termination of a Material Definitive Agreement | 8-K | 8-K ↗ |
| Oct 31, 2024 | EDSA Edesa Biotech, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
44 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 4:54 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances